A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

More encouraging news has been announced about the new, twice-yearly PrEP injection currently undergoing trials. Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has ...

A new type of PrEP injection, requiring only three injections a year, could be on the way. The FDA approved injections of cabotegravir in 2021 as a form of PrEP, to minimize the risk of acquiring HIV.

A new HIV prevention injection is now available to a select number of people in South Africa. That a single shot provides two months of protection is one of the injection's major selling points. The ...

Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

On top of offering various PrEP and PEP medications to students, Student Health expanded its HIV prevention medications this semester with lenacapavir, a twice-per-year injection the Food and Drug ...

A newly approved twice-yearly injection for HIV prevention has rejuvenated hope in the national and global drive to end HIV/Aids as a public health threat by 2030. Lenacapavir, the groundbreaking ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to prevent HIV—a milestone in the decadeslong fight against a once-devastating ...

New HIV prevention era led by twice-yearly injection lenacapavir and other PrEP options HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable ...